Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EPACADOSTAT for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where EPACADOSTAT was used for Neoplasm malignant.

Most Reported Side Effects for EPACADOSTAT

Side Effect Reports % Deaths Hosp.
Dyspnoea 12 12.4% 3 11
Diarrhoea 9 9.3% 2 9
Febrile neutropenia 9 9.3% 0 9
Pyrexia 9 9.3% 3 9
Abdominal pain 8 8.3% 3 8
Syncope 8 8.3% 1 8
Anaemia 7 7.2% 2 7
Sepsis 7 7.2% 2 7
Vomiting 7 7.2% 2 7
Fatigue 6 6.2% 1 5
Acute kidney injury 5 5.2% 1 5
Dehydration 5 5.2% 1 5
Exfoliative rash 5 5.2% 0 5
Nausea 5 5.2% 2 5
Neutropenia 5 5.2% 1 5

Other Indications for EPACADOSTAT

Non-small cell lung cancer (19) Malignant melanoma (8) Non-small cell lung cancer metastatic (7) Product used for unknown indication (6) Diffuse large b-cell lymphoma (5)

Other Drugs Used for Neoplasm malignant

PALBOCICLIB (1,996) CAPECITABINE (1,493) PEMBROLIZUMAB (1,135) PACLITAXEL (984) CARBOPLATIN (977) NIVOLUMAB (947) OXALIPLATIN (823) PAZOPANIB (716) CYCLOPHOSPHAMIDE (685) FLUOROURACIL (676)

Related Pages

EPACADOSTAT Full Profile All Neoplasm malignant Drugs EPACADOSTAT Demographics EPACADOSTAT Timeline